Quality of Life Assessment Through OHIP-14 in Head and Neck Cancer Patients Undergoing Anticancer Therapy and Dental Treatment

2016 ◽  
Vol 94 (4) ◽  
pp. 915
Author(s):  
A.C. Scaraficci ◽  
P.S.S. Santos ◽  
M.P.L. Battisti ◽  
R. Bastos
Keyword(s):  
Quality Of Life ◽  
Head And Neck Cancer ◽  
Head And Neck ◽  
Cancer Patients ◽  
Neck Cancer ◽  
Dental Treatment ◽  
Anticancer Therapy ◽  
Life Assessment ◽  
Quality Of Life Assessment

Quality of Life Assessment in Patients With Head and Neck Cancer

2015 ◽  
Vol 120 (2) ◽  
pp. e83
Author(s):  
ROGÉRIA LUCIO DE OLIVEIRA ◽  
RAFAELLE FERREIRA DOS SANTOS ◽  
SÉRGIO HENRIQUE GONÇALVES DE CARVALHO ◽  
SANDRA APARECIDA MARINHO ◽  
TÁSSIA CRISTINA DE ALMEIDA PINTO SARMENTO ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Head And Neck Cancer ◽  
Head And Neck ◽  
Neck Cancer ◽  
Life Assessment ◽  
Quality Of Life Assessment

scholarly journals A systematic review of head and neck cancer quality of life assessment instruments

Oral Oncology ◽  
2012 ◽  
Vol 48 (10) ◽  
pp. 923-937 ◽  
Author(s):  
Bukola Ojo ◽  
Eric M. Genden ◽  
Marita S. Teng ◽  
Kathrin Milbury ◽  
Krzysztof J. Misiukiewicz ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Systematic Review ◽  
Head And Neck Cancer ◽  
Head And Neck ◽  
Neck Cancer ◽  
Life Assessment ◽  
Assessment Instruments ◽  
Quality Of Life Assessment

QOL assessment in head and neck cancer patients undergoing neoadjuvant chemotherapy and its impact on overall survival.

2019 ◽  
Vol 37 (15_suppl) ◽  
pp. e17519-e17519
Author(s):  
Sachin Dhumal ◽  
Vijay Maruti Patil ◽  
Vanita Noronha ◽  
Amit Joshi ◽  
Atanu Bhattacharjee ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Head And Neck Cancer ◽  
Neoadjuvant Chemotherapy ◽  
Head And Neck ◽  
Cancer Patients ◽  
Neck Cancer ◽  
Treatment Options ◽  
Life Assessment ◽  
The Mean

e17519 Background: NACT (neoadjuvant chemotherapy) is one of the treatment options in advanced head and neck cancer (H&N cancer); however there is limited quality of life data available in these patients. Methods: Between August 2013- April 2014, 90 technically unresectable H&N cancer patients who were underwent NACT at our centre were selected for this analysis. EORTC QLQ-C30 and HN35 version 3.0 was used for quality of life assessment at baseline and after 02 cycles of NACT. PFS and OS was estimated by Kaplan Meier method. The mean change in QOL at various domains was calculated with 95% CI. The relationship between change in QOL domain and OS was analysed. Results: The median age of the cohort was 45 years (Range 21-65 years). The predominant subsite was oral cavity, in 62 patients (68.9%).The median PFS and OS was 10.53 months (95%CI 8.1-13.0) and 20.8 months (95%CI 15.1-26.5). The mean scores for all domains of QOL are shown in table 1. Conclusions: NACT leads to improvement in QOL in patients treated with head and neck cancers and its has impact on OS.[Table: see text]

Evolution of quality of life assessment in head and neck cancer

1995 ◽  
Vol 109 (11) ◽  
pp. 1029-1035 ◽  
Author(s):  
Randall P. Morton
Keyword(s):  
Quality Of Life ◽  
Head And Neck Cancer ◽  
Head And Neck ◽  
Neck Cancer ◽  
Life Assessment ◽  
Head And Neck Oncology ◽  
Quality Of Life Assessment ◽  
Cross Sectional ◽  
Over 40 Years

AbstractQuality of life assessment as part of clinical practice in head and neck oncology began over 40 years ago. Early studies were narrative and cross-sectional; these were followed, at first, by simple quantitative measures of various parameters and later by longitudinal studies of greatercomplexity. More recently quality of life has been employed in a randomized clinical trial of head and neck cancer.Quality of life has evolved to become a standard means of assessing clinical outcomes, and an accepted end point measurement in clinical trials, to be considered alongside survivorship and side effects/complications.

Sign in / Sign up

Export Citation Format

Share Document